Cargando…

Equivalent VTE rates after total joint arthroplasty using thromboprophylaxis with aspirin versus potent anticoagulants: retrospective analysis of 4562 cases across a diverse healthcare system

BACKGROUND: Guidelines support aspirin thromboprophylaxis for primary total hip and knee arthroplasty (THA and TKA) but supporting evidence has come from high volume centers and the practice remains controversial. METHODS: We studied 4562 Medicare patients who underwent elective primary THA (1736, 3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matzko, Chelsea, Berliner, Zachary P., Husk, Gregg, Mina, Bushra, Nisonson, Barton, Hepinstall, Matthew S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796388/ https://www.ncbi.nlm.nih.gov/pubmed/35236505 http://dx.doi.org/10.1186/s42836-021-00101-8

Ejemplares similares

Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start)
por: Amin, A., et al.
Publicado: (2009)

Impact of Acetabular Implant Design on Aseptic Failure in Total Hip Arthroplasty
por: Coden, Gloria, et al.
Publicado: (2021)

Aspirin thromboprophylaxis in joint replacement surgery
por: Sharda, Anish V., et al.
Publicado: (2022)

Arrival and magnetization of carbonaceous chondrites in the asteroid belt before 4562 million years ago
por: O’Brien, Timothy, et al.
Publicado: (2020)

Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
por: van der Wall, Sake J., et al.
Publicado: (2018)

Menstruation, anticoagulation, and contraception: VTE and uterine bleeding
por: Samuelson Bannow, Bethany, et al.
Publicado: (2021)

Extended anticoagulation for VTE: what evidence justifies it?
por: Walia, Anushka, et al.
Publicado: (2023)

Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery
por: Wei, Qingqing, et al.
Publicado: (2023)

Impingement Resulting in Femoral Notching and Elevated Metal-Ion Levels After Dual-Mobility Total Hip Arthroplasty
por: Matzko, Chelsea, et al.
Publicado: (2020)

Duration of anticoagulant therapy and VTE recurrence in patients with cancer
por: Khorana, Alok A., et al.
Publicado: (2019)

How to Build the Plane While Flying: VTE/PE Thromboprophylaxis Clinical Guidelines for COVID-19 Patients
por: Costa, Alessandro, et al.
Publicado: (2020)

A Longitudinal Study of Thrombosis and Bleeding Outcomes With Thromboprophylaxis in Pregnant Women at Intermediate and High Risk of VTE
por: Schapkaitz, E., et al.
Publicado: (2023)

Routine Postoperative Aspirin for VTE Chemoprophylaxis in Primary Total Ankle Arthroplasty
por: Sidhu, Verinder, et al.
Publicado: (2022)

Aspirin as Thromboprophylaxis in Orthopedic Surgery: A Matter of Perspective
por: Schutgens, Roger E.G., et al.
Publicado: (2023)

Blood Being Tricky: Anticoagulation-Resistant Venous Thromboembolism (VTE)
por: Tiperneni, Raghu, et al.
Publicado: (2022)

Incidence of Symptomatic Venous Thromboembolism (VTE) in 8,885 Elective Total Hip Arthroplasty Patients Receiving Post-operative Aspirin VTE Prophylaxis
por: Coveney, Eamonn I, et al.
Publicado: (2023)

SpaVerb-WN—A megastudy of naming times for 4562 Spanish verbs: Effects of psycholinguistic and motor content variables
por: Miguel-Abella, Romina San, et al.
Publicado: (2021)

Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment
por: Burnett, Allison E., et al.
Publicado: (2016)

Thromboprophylaxis and anticoagulation for inpatients with COVID-19 in 2022 and beyond
por: Dalager-Pedersen, Michael
Publicado: (2022)

Aspirin for thromboprophylaxis in major orthopedic surgery: old drug, new tricks?
por: Lippi, Giuseppe, et al.
Publicado: (2018)

Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score
por: de Winter, Maria A, et al.
Publicado: (2023)

Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE
por: Xiong, Wei, et al.
Publicado: (2023)

Role of Direct Oral Anticoagulation Agents as Thromboprophylaxis in Antiphospholipid Syndrome
por: Arora, Shreya, et al.
Publicado: (2021)

Aspirin provides adequate VTE prophylaxis for patients undergoing hip preservation surgery, including periacetabular osteotomy
por: Azboy, Ibrahim, et al.
Publicado: (2018)

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis
por: Cuker, Adam, et al.
Publicado: (2022)

Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
por: Lecumberri, Ramón, et al.
Publicado: (2021)

New Oral Anticoagulants for Thromboprophylaxis after Elective Total Hip and Knee Arthroplasty
por: Friedman, Richard J.
Publicado: (2010)

The comparison between Caprini and Padua VTE risk assessment models for hospitalised cancer patients undergoing chemotherapy at the tertiary oncology department in Poland: is pharmacological thromboprophylaxis overused?
por: Łukaszuk, Robert F., et al.
Publicado: (2018)

Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended Thromboprophylaxis
por: Spyropoulos, Alex C., et al.
Publicado: (2020)

The risk of recurrent VTE and major bleeding in a commercially‐insured population of cancer patients treated with anticoagulation
por: Khorana, Alok A., et al.
Publicado: (2018)

Subgroup Analysis of Patients with Cancer in XALIA: A Noninterventional Study of Rivaroxaban versus Standard Anticoagulation for VTE
por: Ageno, Walter, et al.
Publicado: (2017)

Trial Protocol: A randomised controlled trial of extended anticoagulation treatment versus routine anticoagulation treatment for the prevention of recurrent VTE and post thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (The ExACT Study)
por: Tullett, Jayne, et al.
Publicado: (2013)

Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban, Enoxaparin, or Aspirin for Thromboprophylaxis
por: Lindquist, Desirae E., et al.
Publicado: (2018)

Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial
por: Spyropoulos, Alex C., et al.
Publicado: (2022)

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
por: Cuker, Adam, et al.
Publicado: (2021)

VTE risk assessment in pregnancy
por: Ewins, Karl, et al.
Publicado: (2019)

Are Patients with Active Cancer and Those with History of Cancer Carrying the Same Risks of Recurrent VTE and Bleeding While on Anticoagulants?
por: Frere, Corinne, et al.
Publicado: (2020)

Direct oral anticoagulants (DOAC) for prevention of recurrent arterial or venous thromboembolic events (ATE/VTE) in myeloproliferative neoplasms
por: Huenerbein, Karlo, et al.
Publicado: (2020)

Poor warfarin anticoagulation in long-term thromboprophylaxis: a survey in a southern Croatian county
por: Knežević, Aleksandar, et al.
Publicado: (2019)

Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE
por: Ensor, Joie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2q2dl1vipmkidf4vgjs9ptbqpf